Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 701 - 750 out of 6,635

Document Document Title
WO/1984/000964A1
Cephalosporin compounds represented by the general formula (I), wherein R1 represents alkyl, alkenyl, substituted or unsubstituted aryl, substituted or unsubstituted arylmethyl, or substituted or unsubstituted phenoxymethyl, and R2 repre...  
WO/1984/000965A1
2-Substituted cephem derivatives represented by the general formula (I), (wherein R1 represents substituted or unsubstituted phenyl, substituted or unsubstituted phenylmethyl, or substituted or unsubstituted phenoxymethyl, R2 represents ...  
WO/1983/003968A1
The subject compounds, which are adapted for the site-specific/sustained delivery of centrally acting drug species to the brain, are: (a) compounds of the formula: ADD-DHC BD (I), wherein ADD BD is a centrally acting drug species, and AD...  
WO/1982/001004A1
A process for preparing cephalosporin compounds represented by the following general formula (III): (FORMULA) (wherein R represents a hydrogen atom or a methyl group) or the pharmaceutically acceptable salts thereof, which comprises reac...  
WO/1980/000337A1
A primary alcohol or an aldehyde is reacted with ammonia or a primary or secondary amine together with a molecular oxygen-containing gas in the presence of a palladium or platinum catalyst under oxidative condition to prepare a correspon...  
JP2018193388A
To provide broad spectrum β-lactamase inhibitors that exhibit potent antibiotic activity.The invention provides compounds represented by the formula in the figure designed such that, on cleavage of the β-lactam ring, reactive moieties ...  
JP2018188454A
To provide: broad spectrum β-lactamase inhibitors designed such that, upon cleavage of the β-lactam ring, reactive moieties are generated which can inactivate β-lactamase; and methods of making β-lactamase inhibitors and β-lactam an...  
JP6403289B2  
JP2018104420A
To provide a pharmaceutical composition that has antibacterial activity against carbapenem-resistant bacteria.A pharmaceutical composition contains a compound represented by formula (I), its ester body or their pharmaceutically acceptabl...  
JP6346144B2  
JPWO2017002903A1
A medicine constituent which has an antibacterial action to a compound or a carbapenem resistant bacteria in which a powerful antibacterial spectrum is shown is provided to various bacteria containing gram negative bacteria. Formula (I) ...  
JPWO2016175223A1
The medicine constituent which has antibacterial activity to the compound and carbapenem resistant bacteria in which a powerful antibacterial spectrum is shown is provided to various bacteria containing gram negative bacteria and/or gram...  
JP2017524731A5  
JP2016538244A5  
JP2017193558A
To provide: novel β-lactam-containing compounds as β-lactamase inhibitors having broad antimicrobial spectra; and pharmaceutical compositions containing the compounds.The invention provides compounds represented by the formula I, and p...  
JP2015534995A5  
JP2017524731A
Inside of [type which is a thing explaining the compound in which this application is expressed by formula (I), and Y, It is a bioactive organicity core machine containing one or more aryl groups, a heteroaryl aryl group, non-aromatic hy...  
JPWO2016035847A1
By the present invention, it is formula (IV) :(Inside of a formula, R)1Blocking group [of a Is amino group] ;R2And R3 Are independence is achieved and it is a blocking group of a Carboxy machine. The compound shown, the salt permitted on...  
JP6144669B2  
JP2017513820A
The present invention relates to an active substance of an inorganic cation and organic negative ion, and an inorganic organicity hybrid compound as an ionic compound which comprises organic negative ion fluorescence pigment arbitrarily....  
JPWO2016035845A1
It is a lower type by the present invention (IA) : It comes out and acid addition salt of a compound shown, sodium salt, those hydrates, or those stable crystalline solids are provided. Salt concerned or a crystalline solid is very usefu...  
JP6120429B2  
JP2016521291A5  
JPWO2014104148A1
Formula:(The inside of a formula and W are *CH (s).)2* etc. -- it is -- U is *S* etc. -- R1It is Replace or an unsubstituted carbocyclic machine, and is R.2AAnd R2BIt is a or b given in The specification , and is R.3It is Is a hydrogen a...  
JP2016538244A
[Subject] [Means for Solution] The present invention provides a compound of formula I. A*L*B The inside of [type and A are Zn (s).2+An alternative oleophilic chelate portion is meant to ion; L is a covalent bond or a linker and is;B, for...  
JP2015535210A5  
JP2015531378A5  
JP6006201B2  
JP5974083B2  
JP2016521291A
Use of new red shift luciferin derivatives and those compounds is provided. [Chosen drawing] Nothing  
JP2016519163A
The present invention relates to new crystal form voice of Cefditoren pivoxil with easy conversion in a non-fixed form used as an active ingredient of a medicine, and high purity as Cefditoren pivoxil , and a manufacturing method for the...  
JP2016079098A
To provide a cephem compound having a wide antibacterial spectrum and especially exhibiting strong antibacterial activities against β-lactamase producing Gram-negative bacteria and to provide a pharmaceutical composition comprising the ...  
JP5909441B2  
JP2016047827A
To provide: cefquinome acid addition salt particles that have physical stability; and suspensions of cefquinome acid addition salt that are more stable, preferably cefquinome sulfate particles.An acid, preferably sulfuric acid, is added ...  
JP5864547B2  
JP5859436B2  
JP5852559B2  
JP5852562B2  
JP2015535849A
The present invention is obtained to the functional group in a compound, or the hetero atom of a heterocyclic system by producing and cheating out of the covalent bond of the ornamentation agent of the structure specified by formula 1, T...  
JP2015535210A
The present invention relates to a manufacturing method of an intermediate for manufacturing 2* Alkyl cephem compound useful as an antibacterial medicine. The present invention oxidizes a compound shown by formula (I), or its salt, and p...  
JP2015534995A
The compound of formula (I) of the present invention has an extensive antibacterial spectrum, and is related with 2* substitution cephem compound in which powerful antibacterial activity is especially shown to beta* lactamase production ...  
JP2015531378A
Sample 、 of the constituent containing beta lactam compound and crystalline タゾバクタム arginine, related methods, and these constituents is provided by this indication.  
JP2015155435A
[Subject] Offer of broadband-spectrum beta* lactamase inhibition medicine in which powerful antibacterial activity is shown. [Means for Solution] A compound denoted by formula (I) designed so that a compound might produce a reactant port...  
JP2014513700A5  
JP5733856B2  
JPWO2013051597A1
式(I)[式中、Aは、式(i)〜(iii )のいずれかであり、Bは式(v)または( vi)であり、Eは、置換もしくは非置換の カチオン性窒素原子を有する複素環式基...  
JPWO2013051597A
A is either of formula (i) * (iii) s among a formula (I) [type. B is formula (v) or (vi) and E is a heterocyclic machine which has substitution or an unsubstituted cationic nitrogen atom. Salt permitted on the compound shown by], or its ...  
JPWO2013002215A
The present invention has an extensive antibacterial spectrum and provides a new molecular entity in which strong antibacterial activity is especially shown to beta* lactamase production gram negative bacteria. Specifically, the present ...  
JPWO2013002215A1
本発明は、広範な抗菌スペクトルを有し、特 にβ−ラクタマーゼ産生グラム陰性菌に対し い抗菌活性を示す新規化合物を提供する。 体的には、本発明は、式(I)(式中...  
JP2014528965A
The present invention is a cephalosporin antibacterial-properties compound of formula (I) :Or it is related with the treating method of the infection caused especially with Gram-negative bacteria of the corresponding pharmacologically pe...  

Matches 701 - 750 out of 6,635